News Category
VERAXA Biotech's adoption of FDA-aligned New Approach Methodologies could accelerate clinical advancement and cut animal testing by up to 95% in precl...
Lantern Pharma's regulatory and IRB approvals in Taiwan for the Phase 2 HARMONIC trial of LP-300 in EGFR L858R-mutated lung cancer could speed up deve...
VERAXA Biotech is implementing FDA-aligned New Approach Methodologies that could reduce animal testing by up to 95% while accelerating clinical advanc...
A new study reveals that the skull contains lymph node-like structures that could act as a local immune defense for the brain, opening potential new a...
GeoVax's enhanced MVA-X vaccine candidate achieved durable single-dose protection against highly pathogenic Clade I mpox virus and other orthopoxvirus...
Onco-Innovations is integrating manufacturing, preclinical, and regulatory activities for its lead cancer candidate ONC010, aiming to enable a potenti...
Experts emphasize that asking about clinical trials at the first appointment for small cell lung cancer can unlock promising new treatments and improv...
Telomir Pharmaceuticals' Telomir-Zn inhibited growth in human and canine osteosarcoma cell lines at similar low concentrations, supporting further stu...
Dr. Wael Sakr has announced a one-time $1,000 scholarship for undergraduate pre-med students, aiming to ease financial burdens and encourage commitmen...
Creative Biolabs has broadened its single-cell and single-nucleus RNA sequencing and multi-omics services, enabling researchers to overcome sample-pro...
A comprehensive review reveals that the tumor microenvironment actively reprograms natural killer cells into distinct subsets with specialized roles, ...
The September 17 Life Sciences Virtual Investor Forum will feature live presentations and Q&A from seven companies developing therapies in oncology, f...
VERAXA Biotech's appointment of Dr. Christoph Erkel as chief scientific officer strengthens its leadership as it advances its BiTAC® T-cell engager an...
Quantum BioPharma's Lucid-MS, a first-in-class PAD2 inhibitor, is moving into a Phase 2 trial for multiple sclerosis following FDA clearance of its IN...
Onco-Innovations' CMO discussed ONC010, a novel PNKP inhibitor with dual selectivity mechanisms, and its planned first-in-human trial, underscoring th...
Quantum BioPharma's Lucid-MS has received FDA clearance to begin a Phase 2 trial in multiple sclerosis, marking a key step for a first-in-class therap...
Kairos Pharma's CEO will present at a major investment conference, underscoring the company's lead candidate ENV-105, which targets CD105 to reverse d...
GeoVax applauds the new global mpox vaccine stockpile initiative, highlighting its GEO-MVA candidate as a potential additional source to ensure sustai...
VERAXA Biotech's appointment of Raju Willener as CFO signals its commitment to advancing its BiTAC platform and oncology pipeline with seasoned financ...
Onco-Innovations advances its oncology pipeline toward clinical trials by securing manufacturing readiness, IND-enabling progress, and funding, positi...
OS Animal Health's participation in the Moody Capital Solutions conference highlights its progress in developing OST-HER2, a promising immunotherapy f...
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS, a first-in-class drug targeting myelin repair, signals a potential breakthrough in ...
Researchers at Washington University School of Medicine have advanced laser interstitial thermal therapy (LITT) as a promising alternative to open sur...
Quantum BioPharma's FDA clearance for a phase 2 trial of Lucid-MS, a first-in-class myelin repair candidate, marks a pivotal step toward addressing th...
NanoViricides has registered its Phase II trial for NV-387 Oral Gummies against Ebola in the Pan African Clinical Trials Registry, marking a critical ...
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials for multiple sclerosis marks a significant step toward a novel therapy targe...
The article highlights the historic decline in youth tobacco use while emphasizing the need for adult smokers to have access to accurate information a...
A large study reveals that the timing of brain metastasis development significantly impacts survival in colorectal cancer patients, highlighting the n...
Onco-Innovations reports significant progress on its PNKP inhibitor ONC010, including high-purity API production and a novel catalyst, positioning it ...
VERAXA Biotech's appointment of Raju Willener as CFO signals a strategic move to bolster its financial leadership and advance its proprietary BiTAC te...
OS Therapies' participation in the Moody Capital Conference comes as the company anticipates critical regulatory decisions and data releases for its l...
A Swiss preclinical study reveals that administering immunotherapy before surgery significantly improves outcomes for glioblastoma patients, a finding...
New research from Mass General Brigham reveals that unintended radiation to the thymus during lung cancer treatment is associated with poorer clinical...
Salman Fazal, MD, a hematologist and transplant specialist at UPMC Hillman Cancer Center, has been named a 2026 Castle Connolly Top Doctor for the thi...
NanoViricides is progressing its measles drug NV-387 to Phase II trials, leveraging FDA designations and strong preclinical data, which could address ...
TransCode Therapeutics' lead candidate TTX-MC138 shows significant survival benefits in a preclinical breast cancer bone metastasis model, supporting ...
A nurse's personal battle with metastatic triple-negative breast cancer underscores the importance of new antibody-drug conjugates as first-line treat...
An expert and a patient discuss the importance of PSMA testing in guiding prostate cancer treatment, emphasizing the need for patients to advocate for...
The NMPA approval allows Heidelberg Pharma and Huadong Medicine to initiate a Phase Ib/II trial of HDP-101 in combination therapies for relapsed/refra...
A new study published in Critical Care Medicine reveals that VolitionRx's Nu.Q NETs H3.1 biomarker independently predicts 28-day mortality and need fo...
Novogenia AG's U.S. launch of the MGT Plus methylation test, which analyzes 27 genes across six pathways, marks a significant expansion in personalize...
Citius Pharmaceuticals' transition to a commercial-stage biopharma, driven by LYMPHIR's revenue and a promising late-stage pipeline, underscores its s...
Annovis Bio announced a corporate update webinar to discuss progress and milestones for its Alzheimer's and Parkinson's programs, including the fully ...
A new study suggests that personalized mRNA vaccines derived from patients' tumor tissue can prevent melanoma recurrence for years, highlighting the p...
Dr. David Zelby, a Marietta prosthodontist with over 40 years of experience, has been named a 2026 Castle Connolly Top Dentist, an honor reflecting pe...
Creative Biolabs announces a webinar featuring Dr. Greg M. Delgoffe to discuss modeling T cell dysfunction in the tumor microenvironment, highlighting...
A novel T cell therapy offers a potential new treatment option for patients with recurrent glioblastoma, a condition with few effective therapies, hig...
VERAXA Biotech and Secarna Pharmaceuticals announced initial positive results from their collaboration to develop antibody oligonucleotide conjugates,...
